The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.

Nils Koch-Henriksen; Per Soelberg Sørensen; Klaus Bendtzen; Esben Meulengracht Flachs

doi:10.1177/1352458508101946

The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.

Nils Koch-Henriksen
, Per Soelberg Sørensen
, Klaus Bendtzen
, Esben Meulengracht Flachs

Det Sundhedsvidenskabelige Fakultet

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Multiple sclerosis
Vol/bind	15
Udgave nummer	5
Sider (fra-til)	601-605
ISSN	1352-4585
DOI	https://doi.org/10.1177/1352458508101946
Status	Udgivet - 2009

Dokumenter og links

10.1177/1352458508101946

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{ddfc2240004b11dfaefb000ea68e967b,

title = "The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.",

author = "Nils Koch-Henriksen and S{\o}rensen, \{Per Soelberg\} and Klaus Bendtzen and Flachs, \{Esben Meulengracht\}",

year = "2009",

doi = "10.1177/1352458508101946",

language = "English",

volume = "15",

pages = "601--605",

journal = "Multiple sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications",

number = "5",

}

The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis. / Koch-Henriksen, Nils; Sørensen, Per Soelberg; Bendtzen, Klaus et al.
I: Multiple sclerosis, Bind 15, Nr. 5, 2009, s. 601-605.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.

AU - Koch-Henriksen, Nils

AU - Sørensen, Per Soelberg

AU - Bendtzen, Klaus

AU - Flachs, Esben Meulengracht

PY - 2009

Y1 - 2009

U2 - 10.1177/1352458508101946

DO - 10.1177/1352458508101946

M3 - Journal article

SN - 1352-4585

VL - 15

SP - 601

EP - 605

JO - Multiple sclerosis

JF - Multiple sclerosis

IS - 5

ER -